Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
MENLO PARK, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- SPARK NS today announced the nine projects and principal investigators selected for the SPARK NS Translational Research Program, 2026 Cohort....
-
Austin, United States, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Drug Discovery Informatics Market Size & Growth Analysis: According to SNS Insider, The Drug Discovery Informatics Market size is...
-
BCC Research report, “Botanical and Plant-derived Drugs: Global Markets” is expected to grow from $38.7 billion in 2025 to $58.1 billion by the end of 2030
-
SPARK NS and Haukeland University Hospital Announce Clinical Trial of D-Serine for Modifying Parkinson’s Disease Progression
-
DURHAM, NC and LONDON, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Polarean, a commercial-stage medical imaging company advancing functional MRI of the lungs, today announced the expansion of its Xenon MRI...
-
Precede Biosciences Secures $83.5M in Total Financing to Scale Next-Generation Precision Diagnostics Platform
-
Avance Clinical will meet biotech sponsors at Biotech Showcase 2026 in San Francisco, highlighting the launch of the new Early Phase Center of Excellence.
-
First patient dosed and study open in leading oncology centers in US and AustraliaPhase I/IIA adaptive study aims to assess and optimize the dose of OTP-01 and provide safety, tolerability, and early...
-
Taipei, Taiwan, Jan. 06, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and...
-
Cyclerion & Medsteer entered a strategic agreement to enable the integration of Medsteer's technology and know-how into CYC-126.